Search

Coherus Oncology Inc

Suletud

SektorTervishoid

1.66 5.73

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.53

Max

1.7

Põhinäitajad

By Trading Economics

Sissetulek

-279M

-38M

Müük

-438K

12M

P/E

Sektori keskmine

3.509

60.549

Aktsiakasum

-0.25

Kasumimarginaal

-308.197

Töötajad

145

EBITDA

9.3M

-34M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+394.01% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-19M

241M

Eelmine avamishind

-4.07

Eelmine sulgemishind

1.66

Uudiste sentiment

By Acuity

50%

50%

171 / 342 Pingereas Healthcare

Coherus Oncology Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. juuli 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7. juuli 2026, 23:43 UTC

Social Media
News

Apple Inc. shares rose in after-hours trading, bolstered by a significant gain in a call option and an extended partnership with Broadcom through 2031.

7. juuli 2026, 23:41 UTC

News

Concerns over Middle East tensions and rising oil prices support gains in iShares 7-10 Year Treasury Bond ETF during after-hours trading.

7. juuli 2026, 23:41 UTC

Social Media
Correlated Moves
News

NVIDIA shares are lower in after-market trading as Michael Burry initiates short positions, citing concerns over reduced AI spending among businesses.

7. juuli 2026, 23:41 UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is higher in after-market trading, supported by gains from key holdings despite broader market pressures and geopolitical tensions.

7. juuli 2026, 23:41 UTC

ETF Constituents
Social Media
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in Invesco QQQ Trust during after-market hours, reflecting broader market concerns.

7. juuli 2026, 23:36 UTC

ETF Constituents
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in the Vanguard Growth ETF during after-market hours.

7. juuli 2026, 23:21 UTC

Social Media
News

Meta Platforms Inc. has gained after launching its Muse Image generator, enhancing user engagement despite facing $1.4 trillion in legal challenges.

7. juuli 2026, 23:06 UTC

News

Geopolitical tensions rise after U.S. strikes on Iran, while the Reserve Bank of New Zealand is set to announce a rate hike. The ETF traded roughly flat in after-market hours.

7. juuli 2026, 23:06 UTC

News

The United States Oil Fund LP is trading higher after military strikes against Iran escalated tensions, contributing to gains in WTI crude prices above $72.50.

7. juuli 2026, 23:06 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market trading amid broader market declines and concerns over chip stocks following Samsung's earnings report.

7. juuli 2026, 23:02 UTC

Correlated Moves
News

Silver is lower in after-market hours, reflecting declines since Tuesday's close amid rising tensions from U.S. military actions and expectations of a New Zealand rate hike.

7. juuli 2026, 23:01 UTC

ETF Constituents
Macro News
News

The Industrial Select Sector SPDR Fund declined in after-market hours amid geopolitical tensions and a hawkish Fed stance, impacting operating margins in the industrial sector.

7. juuli 2026, 23:01 UTC

Social Media
News

T-Mobile US Inc. appointed Chris Sambar as Chief Enterprise Officer, effective by October 14, 2026, and shares traded higher in after-market hours.

7. juuli 2026, 22:51 UTC

News

PayPal shares are lower in after-market hours following Barclays' Underweight rating and price target of $42.00, amid broader market weakness and geopolitical tensions.

7. juuli 2026, 20:07 UTC

News
Correlated Moves

Bitcoin declines amid geopolitical tensions following missile attacks in the Strait of Hormuz. Regulatory approval for Bitcoin Suisse in the UAE adds complexity to investor sentiment.

7. juuli 2026, 20:07 UTC

Correlated Moves
News

Bitcoin is lower today amid rising geopolitical tensions and concerns over oil supply disruptions. Ethereum's decline may also influence Bitcoin's price movement.

7. juuli 2026, 20:06 UTC

Social Media
News
Correlated Moves

Synopsys Inc. is discontinuing its manufacturing process control software for semiconductor makers, shifting focus to AI design offerings. Shares are trading lower today.

7. juuli 2026, 20:06 UTC

Social Media
News

Amazon.com Inc shares are higher following a $25 billion bond sale to fund AI infrastructure, attracting $62 billion in demand and receiving an 'AA-' rating from Fitch.

7. juuli 2026, 20:06 UTC

News
Social Media
Correlated Moves

Broadcom Inc shares are lower today following a downgrade to Hold by Erste Group, amid broader declines in the semiconductor sector.

7. juuli 2026, 20:06 UTC

News
Correlated Moves

Ethereum is trading lower following a suspicious transaction linked to an exploiter, resulting in estimated losses of around $6 million.

7. juuli 2026, 20:04 UTC

News
Social Media

Tesla Inc. shares are lower today amid criticism of CEO Elon Musk's governance linked to negative brand perception, despite RBC raising its price target to $500.

7. juuli 2026, 20:03 UTC

Social Media
News

Fiserv is in talks to sell its debit card network for about $15 billion. Shares are trading lower amid market volatility despite earlier gains.

7. juuli 2026, 20:03 UTC

News
Correlated Moves

Analog Devices has completed its acquisition of Empower Semiconductor to enhance AI capabilities. Shares are declining amid broader market pressures affecting the semiconductor sector.

7. juuli 2026, 20:02 UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

7. juuli 2026, 19:52 UTC

Social Media
News
Correlated Moves

Alphabet Inc. is under investigation in Nigeria for alleged anti-competitive practices, contributing to a decline in shares during Tuesday's session.

7. juuli 2026, 19:46 UTC

News
Social Media
Correlated Moves

Costco faces scrutiny from a class-action lawsuit alleging toxic heavy metals in its protein products, contributing to shares trading lower since Monday's close.

7. juuli 2026, 19:44 UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

7. juuli 2026, 19:36 UTC

News
Correlated Moves

Ethereum is trading lower amid a suspicious transaction linked to an exploiter, resulting in estimated losses of $6 million and concerns over price manipulation.

7. juuli 2026, 19:36 UTC

News
Social Media

Vertex Pharmaceuticals shares are lower today following its $10 billion acquisition of Crinetics Pharmaceuticals, despite analyst support and price target increases.

Võrdlus sarnastega

Hinnamuutus

Coherus Oncology Inc Prognoos

Hinnasiht

By TipRanks

394.01% tõus

12 kuu keskmine prognoos

Keskmine 8.25 USD  394.01%

Kõrge 12 USD

Madal 4 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Coherus Oncology Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

5

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

171 / 342 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coherus Oncology Inc

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel PD-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype G1 (IgG1) monoclonal antibody targeting interleukin 27. It is also developing CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody selectively targeting CCR8, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, an antibody targeting human ILT4 designed to improve anti-PD-1 clinical benefit by transforming an unfavorable TME to a more favorable TME. In addition, the company's licensed immuno-oncology programs include NZV930, an antibody designed to inhibit cluster of differentiation 73; and GSK4381562, an antibody targeting CD112R for the treatment of solid tumors. Further, it offers YUSIMRY, a biosimilar to Humira for the treatment of patients with inflammatory diseases characterized by increased production of tumor necrosis factor (TNF) in the body, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and ulcerative colitis. It collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreement with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc., as well as Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
help-icon Live chat